Type 2 diabetes and hypertension Not Applicable
Conditions
Interventions
The intervention is not yet established, since this will be done through policy dialogues based upon the formative findings. The focus of the intervention will be the development and deployment of an
improving referral pathways to second-line services, organisations for education and self-management support
appointment systems between different actors and patients
the development of better communication channels
6. Monitoring of individual patients through a medical record system and monitoring at organisational level through a health information system
7. Des
Sponsors
Horizon 2020 programme of the European Union
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The scale-up in Cambodia targets the people using public health services, and in Slovenia and Belgium, the scale-up focuses on vulnerable people. In practice, this will include people who are of old age with multiple morbidities.
Exclusion criteria
Exclusion criteria: There are no exclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The impact evaluation will assess indicators relating to health outcomes and patient-centeredness. These data will be collected for all known T2D and HT patients subscribed to a facility in the areas where scale-up is taking place. There will be at least two measurements: the start of scale-up (beginning of year 2 or any later phase, depending on the phasing of scale-up) and at the end of year 3, preferably more interrupted time series. The difference in time of follow-up will be accounted for in the analyses. The core health outcomes identified are: For T2D : 1. Number of people with T2D: measured by prevalence of year x-1 2. % of people tested for T2D: number of people tested over a certain period 3. % of people diagnosed in year x-1 4. % of people retained in care in year x (past year) 5. % of people being on treatment in year x 6. % of people with good T2D outcomes in year x For hypertension: 1. Number of people with HT: measured by prevalence of year x-1 2. % of people tested for HT: number of people tested over a certain period 3. % of people diagnosed in year x-1 4. % of people linked and retained in care in year x (past year) 5. % of people being on treatment in year x (medication) 6. % of people followed up in year x 7. % of people with good HT outcomes in year x | — |
Secondary
| Measure | Time frame |
|---|---|
| Apart from the impact evaluation (see primary outcome measures), the researchers will do a process evaluation and implementation evaluation, and a cost evaluation of the scale-up process. 1. Reach: number of scaleable units covered by the scale-up, measured using project documents on implementation at baseline and endline 2. Acceptability and feasibility of the scale-up strategy, measured using interviews with stakeholders and participants and questionnaire items to participants included in the follow-up measurements at endline 3. Adaptation of the scale-up strategy, measured using project documents on implementation (continuous) 4. Fidelity of implementation, measured using interviews with stakeholders and observations of work practices at endline The implementation evaluation will cover three dimensions of scale-up: 1. The population coverage: indicators mentioned above / measured at the population level, measured by number of scaleable units covered, by target population living in the area, and (potential) by number of people actually covered by the intervention. Measured at baseline and endline 2. The expansion of the intervention package towards the ICP: number of components added to the ICP, measured at baseline and endline 3. The integration of the intervention into the larger health system. This will be measured at the system level by the presence of sustainable financing arrangements for the ICP, provider payment mechanisms that stimulate health education and self-management, human resource planning for teamwork in facilities and with community, the development of guidelines or care pathways and the development of common monitoring. These measures will be collected through project documents and key informant interviews at endline. The integration at operational level will be measured at operational level using normalisation process theory. The following elements are proposed to be measured at operational (meso-) level: the level of collection action nee | — |
Countries
Belgium, Cambodia, Slovenia
Contacts
Public ContactGrace Marie Ku
Outcome results
None listed